glp-1 receptor agonist blue cross blue shield Why is rolling back coverage of weight loss drugs in Massachusetts BCBS VT nonsensical rationale for

But weve never done an episode like this before, where we talk to one of the most important people in charge of guiding the GLP-1 drug revolution

Neuron , 109 (3), 461-472

doi:10.1053/j.gastro.2025.06.003 13

As researchers learn more about the biological processes involved in appetite and metabolism, weight management shifts from a matter of willpower to a complex but medically treatable condition

Within this loop, nutrient stimulation of GIP secretion enhances GLP-1 release [ Figure 1 Section A]

While inexpensive and simple to perform, its limitations are partitioning in the liquid phase and the inability to assess gastric emptying of solids reliably (31, 35, 36)